Novacyt SA (LON:NCYT)’s stock price was up 9.4% during trading on Thursday . The stock traded as high as GBX 8.75 ($0.11) and last traded at GBX 8.75 ($0.11), approximately 0 shares were traded during mid-day trading. The stock had previously closed at GBX 8 ($0.10).
The company has a debt-to-equity ratio of 26.69, a quick ratio of 0.52 and a current ratio of 1.01. The stock has a market cap of $3.69 million and a PE ratio of -0.33. The business’s 50 day moving average price is GBX 9.
About Novacyt (LON:NCYT)
Novacyt SA develops and sells diagnostic products for cancer and infectious diseases. The company's diagnostic products are used in liquid based cytology, oncology, microbiology, haematology, and serology testing. It offers NovaPrep, a liquid based cytology solution that is utilized in the diagnosis of cervical cancer; and clinical laboratory testing services to clinicians, healthcare providers, and patients.
Featured Story: Equity Income
Receive News & Ratings for Novacyt Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Novacyt and related companies with MarketBeat.com's FREE daily email newsletter.